Fish /

Breed profile · FDA CVM July 2026 extract

Atlantic Salmon (Salmo salar) adverse-event record

Adverse-event filings for Atlantic Salmon (Salmo salar) (Fish) in the FDA Center for Veterinary Medicine openFDA extract. Browse fish breeds, reactions, and outcomes below.

#233 of 510
by report volume (all breeds)
97
FDA CVM reports on file
99.0%
death-coded share of reports
#1 of 275
by death-coded share (≥50 reports)

How the 97 reports break down

By recorded gender -- every report on file for Atlantic Salmon (Salmo salar), no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 16 12 8 4 0 2017 2018 2019 2020 2021 2022 2023 2024 Reports filed Death-coded reports
Annual report volume for Atlantic Salmon (Salmo salar) drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Atlantic Salmon (Salmo salar) is #1 of 275 breeds with at least 50 reports by highest death-coded share (99.0%) at report rank #233 of 510; separately, Retriever - Labrador is #1 by total reports at 93,675 (death-coded-share rank 195).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#233
This breed, reports of 510
#1
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Atlantic Salmon (Salmo salar) has 97 reports now versus 97 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Atlantic Salmon (Salmo salar) changes

Total Reports

97

Above-median volume

Deaths Reported

96

of 97 reports

Death-coded share of reports

99.0%

Highest death-coded share

Avg Age at Report

0.7 yr

0.4 kg avg weight

Death-Coded Outcome Share

Atlantic Salmon (Salmo salar) death-coded reports 99.0%
Cross-breed median

99.0% of 97 atlantic salmon (salmo salar) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Atlantic Salmon (Salmo salar)'s death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

99% 100th percentile Higher share than 100% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). Below this entry. 20%–25%: 2 indexed breeds (1%). Below this entry. 25%–30%: 3 indexed breeds (1%). Below this entry. 30%–35%: 4 indexed breeds (1%). Below this entry. 35%–40%: 5 indexed breeds (2%). Below this entry. 40%–45%: 6 indexed breeds (2%). Below this entry. 45%–50%: 3 indexed breeds (1%). Below this entry. 50%–55%: 7 indexed breeds (3%). Below this entry. 55%–60%: 7 indexed breeds (3%). Below this entry. 60%–65%: 21 indexed breeds (8%). Below this entry. 65%–70%: 11 indexed breeds (4%). Below this entry. 70%–75%: 15 indexed breeds (5%). Below this entry. 75%–80%: 13 indexed breeds (5%). Below this entry. 80%–85%: 11 indexed breeds (4%). Below this entry. 85%–90%: 12 indexed breeds (4%). Below this entry. 90%–95%: 12 indexed breeds (4%). Below this entry. 95%–100%: 142 indexed breeds (52%). This entry sits in this band. Atlantic Salmon (Salmo salar) 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 0.4 kg (0.9 lbs)

Top Reported Reactions

Death 69
IGA Animal mortality greater than expected 41
Fish body deformity 31
Moribund 24
IGA Animal morbidity greater than expected 17

Most Referenced Drugs

Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) 88
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage 7
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) 1
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The Alocus In The Eo-1A Lineage) 1

Outcome Breakdown

Died
69 (60.0%)
Euthanized
42 (36.5%)
Ongoing
4 (3.5%)

Gender Distribution

Female 93 (95.9%)
Unknown 4 (4.1%)

Reports by Year

Year Reports Trend
2015 2
2016 16
2017 12
2018 7
2019 10
2020 16
2021 14
2022 9
2023 10
2024 1

Atlantic Salmon (Salmo salar): high death-coded share in the FDA CVM extract

Signature read: Atlantic Salmon (Salmo salar)'s 99.0% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Atlantic Salmon (Salmo salar) sits at #233 of 510 by report volume among all breeds and #1 of 5 among fish breeds, with 97 reports and 96 (99.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #1 of 275. Mean age at report: 0.7 years, average weight 0.4 kg (0.9 lbs).

Top reported signs: Death (69), IGA Animal mortality greater than expected (41), Fish body deformity (31). Most-referenced drug: Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) (88 reports), followed by Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage (7) and Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) (1).

Outcome coding on 115 status-recorded reports is dominated by Died (60.0%). Annual submissions ranged 1-2,024 across 10 years on file.

Fish Breeds With a Similar Report Volume

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Atlantic Salmon (Salmo salar), both outside the Fish family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (99.0% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (0.4 kg here).

What to do with this fish

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Atlantic Salmon (Salmo salar)?
There are 97 adverse event reports involving Atlantic Salmon (Salmo salar) in the FDA database, of which 96 were death-coded (99.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Atlantic Salmon (Salmo salar) ranks #233 of 510 by report volume among all breeds PlainBreed indexes (#1 of 5 among fish breeds).
Where does Atlantic Salmon (Salmo salar) sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Atlantic Salmon (Salmo salar) is #233 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Fish, it is #1 of 5. Among breeds with at least 50 reports, its death-coded share ranks #1 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Atlantic Salmon (Salmo salar)?
The most commonly reported adverse reactions for Atlantic Salmon (Salmo salar) are Death (69 reports), IGA Animal mortality greater than expected (41 reports), Fish body deformity (31 reports), Moribund (24 reports), IGA Animal morbidity greater than expected (17 reports).
What drugs are most frequently associated with Atlantic Salmon (Salmo salar) adverse events?
The drugs most frequently referenced in Atlantic Salmon (Salmo salar) adverse event reports are Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) (88 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage (7 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) (1 reports), Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The Alocus In The Eo-1A Lineage) (1 reports).
What is the average age of Atlantic Salmon (Salmo salar) in adverse event reports?
The average age of Atlantic Salmon (Salmo salar) at the time of adverse event reports is 0.7 years, with an average weight of 0.4 kg (0.9 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Atlantic Salmon (Salmo salar) (Fish), extract as of July 2026 extract. 97 reports · 96 death-coded (99.0% of reports, not a mortality rate) · #233 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →